Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Celularity Inc. (CELU): This clinical-stage biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 6.4% over the last 60 days.
Celularity, Inc. Price and Consensus
MoneyGram International, Inc. (MGI): This peer-to-peer payments and money transfer services company has seen the Zacks Consensus Estimate for its current year earnings increasing 16.7% over the last 60 days.
MoneyGram International Inc. Price and Consensus
Larimar Therapeutics, Inc. (LRMR): This clinical-stage biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 47.8% over the last 60 days.
Larimar Therapeutics, Inc. Price and Consensus
Paradigm Press Editor's Note:
Hi, my name is Joel Litman.
I'm a forensic accountant and CPA. I consult regularly with the Department of Defense at the U.S. Pentagon… the FBI… and the U.S. Marines War College.
I'm writing you this note because my research team and I have published new research we think it's critical for every American to see.
In a nutshell, we think it's important for you to see our work on:
A Surprising July 25th Twist that Could Enable Joe Biden To Win a 2nd Term Re-election… By a Landslide. (click here to view free of charge on my website)
I know… you probably think that's not possible-but there's a big secret you are probably missing, and today I want to share that secret with you.
I've shared some of this information already, with U.S. Gov't officials at the highest level.
And today I'm going public with my full revelations, discoveries, and recommendations. (my full analysis and data are posted here)
There's good news here… but bad news too.
This secret I want to share with you will likely make millions of Americans vastly wealthier.
But the bad news is that this secret will likely bring Biden and the progressives newfound power, which could enable bigger and more intrusive government. It could push us more towards socialism than ever before.
I believe it will soon be harder than ever to hang onto any money you make.
I outline the entire story and my recommendations on what you should do right now, in my brand-new analysis.
We've posted it on my research firm's website, and you can access it free of charge. Click here to view…
EQRx, Inc. (EQRX): This medicine company focused on oncology and immune-inflammatory diseases has seen the Zacks Consensus Estimate for its current year earnings increasing 12.1% over the last 60 days.
EQRx, Inc. Price and Consensus
Surrozen, Inc. (SRZN): This clinical-stage biotechnology company has seen the Zacks Consensus Estimate for its next year earnings increasing 15.3% over the last 60 days.
Surrozen, Inc. Price and Consensus
The second great EV gold rush is here.
The first one started in 2017, when Tesla sent lithium stocks to the roof..
Like Tianqi Lithium Corporation, which climbed 3,580%.
Or Pilbara Mineral Limited, which rode the lithium boom to 5,320% gains.
And Lithium Americas Corporation – which handed early investors a whopping 9,397% gain.
Just $2,500 into those three plays would have turned into $464,925!
But if you missed those gains, don't worry.
And this time, it doesn't have anything to do with lithium.
Instead, another little-known resource is set to mint a whole new generation of EV millionaires.
The Financial Times is calling it a “gold rush on steroids…”
As Tesla, Apple, and even the U.S. government all race to secure their own supplies of this precious resource.
And if early investors act now, they could have the chance to turn every $500 into $130,085.
Originally published on Zacks.com